BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 28130617)

  • 21. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prolactin as an immunomodulatory factor in psoriatic arthritis].
    Kokot I; Pawlik-Sobecka L; Płaczkowska S; Piwowar A
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1265-72. PubMed ID: 24379267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome.
    Leaños-Miranda A; Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Parra A; Ramírez-Peredo J
    Lupus; 2007; 16(5):342-9. PubMed ID: 17576736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China.
    Qian Q; Liuqin L; Hao L; Shiwen Y; Zhongping Z; Dongying C; Fan L; Hanshi X; Xiuyan Y; Yujin Y
    J Immunol Res; 2015; 2015():316965. PubMed ID: 25973434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperprolactinemia in systemic lupus erythematosus.
    Huang CM; Chou CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jan; 59(1):37-41. PubMed ID: 9134821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
    Paraiba DB; Soares CR; Bartolini P; Arthuso FS; Borba EF; Bonfa E; Bronstein MD
    Clin Exp Rheumatol; 2010; 28(6):866-72. PubMed ID: 21205462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin and autoimmunity.
    De Bellis A; Bizzarro A; Pivonello R; Lombardi G; Bellastella A
    Pituitary; 2005; 8(1):25-30. PubMed ID: 16411065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus.
    Hooghe R; Dogusan Z; Martens N; Velkeniers B; Hooghe-Peters EL
    Lupus; 2001; 10(10):719-27. PubMed ID: 11721698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A; Cárdenas-Mondragón G
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals.
    Gutiérrez MA; Molina JF; Jara LJ; García C; Gutiérrez-Ureña S; Cuéllar ML; Gharavi A; Espinoza LR
    Int Arch Allergy Immunol; 1996 Mar; 109(3):229-35. PubMed ID: 8620091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.
    Yang J; Li Q; Yang X; Li M
    Lupus; 2016 Apr; 25(5):513-9. PubMed ID: 26678441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O; Mendez C; Jara LJ; Cisneros M; Medina G; Ariza R; Espinoza LR
    J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus.
    Rovenský J; Juránková E; Rauová L; Blazícková S; Lukác J; Veselková Z; Jezová D; Vigas M
    J Rheumatol; 1997 Dec; 24(12):2330-4. PubMed ID: 9415637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum levels of cyclo (His-Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patients.
    Jara LJ; Prasad C; Espinoza LR
    Lupus; 1997; 6(3):258-60. PubMed ID: 9104733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin: a stimulator of disease activity in systemic lupus erythematosus.
    Walker SE; Allen SH; Hoffman RW; McMurray RW
    Lupus; 1995 Feb; 4(1):3-9. PubMed ID: 7767336
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolactin and autoimmunity.
    Shelly S; Boaz M; Orbach H
    Autoimmun Rev; 2012 May; 11(6-7):A465-70. PubMed ID: 22155203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.
    Saha S; Tieng A; Pepeljugoski KP; Zandamn-Goddard G; Peeva E
    Clin Rev Allergy Immunol; 2011 Feb; 40(1):8-15. PubMed ID: 19937157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.
    Orbach H; Zandman-Goddard G; Boaz M; Agmon-Levin N; Amital H; Szekanecz Z; Szucs G; Rovensky J; Kiss E; Doria A; Ghirardello A; Gomez-Arbesu J; Stojanovich L; Ingegnoli F; Meroni PL; Rozman B; Blank M; Shoenfeld Y
    Clin Rev Allergy Immunol; 2012 Apr; 42(2):189-98. PubMed ID: 21287295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.